FMISO
Appearance
Clinical data | |
---|---|
Other names | [18F]FMISO; 1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole |
Identifiers | |
| |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C6H818FN3O |
Molar mass | 188.15 g/mol |
FMISO or fluoromisonidazole is used as a PET radiotracer for imaging hypoxia when labeled with fluorine-18.[1]
References
- ^ Rajendran, JG; Mankoff, DA; O'Sullivan, F; Peterson, LM; Schwartz, DL; Conrad, EU; Spence, AM; Muzi, M; Farwell, DG; Krohn, KA (1 April 2004). "Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging". Clinical cancer research : an official journal of the American Association for Cancer Research. 10 (7): 2245–52. PMID 15073099.
External links
- 18F-Fluoromisonidazole, Molecular Imaging and Contrast Agent Database (MICAD)